Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP885688.RAxTFMXXiHYPHUVtrrZ1z4p5uiPxDA10RSiqtMb3naO34130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP885688.RAxTFMXXiHYPHUVtrrZ1z4p5uiPxDA10RSiqtMb3naO34130_assertion type Assertion NP885688.RAxTFMXXiHYPHUVtrrZ1z4p5uiPxDA10RSiqtMb3naO34130_head.
- NP885688.RAxTFMXXiHYPHUVtrrZ1z4p5uiPxDA10RSiqtMb3naO34130_assertion description "[In conclusion, our study has revealed a new mode of PI3K alteration in primary endometrial tumors and warrants future studies to determine whether PIK3R1 mutations correlate with clinical outcome to targeted therapies directed against the PI3K pathway in EEC and NEEC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP885688.RAxTFMXXiHYPHUVtrrZ1z4p5uiPxDA10RSiqtMb3naO34130_provenance.
- NP885688.RAxTFMXXiHYPHUVtrrZ1z4p5uiPxDA10RSiqtMb3naO34130_assertion evidence source_evidence_literature NP885688.RAxTFMXXiHYPHUVtrrZ1z4p5uiPxDA10RSiqtMb3naO34130_provenance.
- NP885688.RAxTFMXXiHYPHUVtrrZ1z4p5uiPxDA10RSiqtMb3naO34130_assertion SIO_000772 21478295 NP885688.RAxTFMXXiHYPHUVtrrZ1z4p5uiPxDA10RSiqtMb3naO34130_provenance.
- NP885688.RAxTFMXXiHYPHUVtrrZ1z4p5uiPxDA10RSiqtMb3naO34130_assertion wasDerivedFrom befree-2016 NP885688.RAxTFMXXiHYPHUVtrrZ1z4p5uiPxDA10RSiqtMb3naO34130_provenance.
- NP885688.RAxTFMXXiHYPHUVtrrZ1z4p5uiPxDA10RSiqtMb3naO34130_assertion wasGeneratedBy ECO_0000203 NP885688.RAxTFMXXiHYPHUVtrrZ1z4p5uiPxDA10RSiqtMb3naO34130_provenance.